FLXU:F:F-Franklin LibertyShares ICAV - Franklin LibertyQ US Equity UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 53.69

Change

-1.30 (-2.36)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-8.40 (-1.42%)

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-1.04 (-1.95%)

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.19 (-1.23%)

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

-3.21 (-3.01%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.17%)

USD 43.00B
0ZC:F Zscaler Inc

-12.70 (-6.77%)

USD 37.92B
BSND:F Danone SA

+0.40 (+3.03%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-1.00 (-0.75%)

USD 24.77B

ETFs Containing FLXU:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.13% 36% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.13% 36% F 47% F
Trailing 12 Months  
Capital Gain 8.66% 52% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.66% 49% F 49% F
Trailing 5 Years  
Capital Gain 82.59% 82% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.59% 82% B 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 15.85% 86% B+ 74% C
Dividend Return 15.85% 84% B 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.80% 64% D 89% A-
Risk Adjusted Return 146.71% 100% F 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike